Donald Wuchterl

Direktor/Vorstandsmitglied bei ABEONA THERAPEUTICS INC.

Vermögen: 329 275 $ am 31.05.2024

54 Jahre

Health Technology

Consumer Services

Aktive Positionen von Donald Wuchterl

Unternehmen	Position	Beginn	Ende
ABEONA THERAPEUTICS INC.	Direktor/Vorstandsmitglied	19.04.2021	-
ABEONA THERAPEUTICS INC.	Independent Dir/Board Member	19.04.2021	-

Unternehmen	Position	Beginn	Ende
T-Knife Therapeutics, Inc.	Corporate Officer/Principal	01.04.2021	01.08.2022
AUDENTES THERAPEUTICS, INC.	Corporate Officer/Principal	01.01.2016	01.01.2021
Cytovance Biologics, Inc. Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.	Geschäftsführer	01.07.2012	01.01.2016

Colorado Technical University, Inc.	Undergraduate Degree
Fitchburg State University	Masters Business Admin

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Director/Board Member	1
Independent Dir/Board Member	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ABEONA THERAPEUTICS INC.	Health Technology

Private Unternehmen	3
Cytovance Biologics, Inc. Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.	Health Technology
Astellas Gene Therapies, Inc. Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA.	Health Technology
T-Knife Therapeutics, Inc.